Toralgen’s insulin-delivering nano-particle therapy accepted into the FDA’s Emerging Technology Program

pills
Toralgen’s technology provides significant promise to the oral delivery of major diabetic therapies following years of promising oral candidates failing to reach the market. Credit: fizkes/Shutterstock.